| Literature DB >> 35292601 |
Su Chan Lim1, Jae Gun Kwak1, Sungkyu Cho1, Jooncheol Min1, Sangjun Lee1, Hye Won Kwon1, Woong-Han Kim1.
Abstract
Background: Surgical repair of partial anomalous pulmonary venous return (PAPVR) to the superior vena cava (SVC) using the Warden procedure has favorable outcomes. However, there remain some concerns after the Warden procedure, such as sinoatrial nodal dysfunction and systemic or pulmonary venous stenosis. We investigated the outcomes of the Warden procedure for repair of PAPVR to the SVC.Entities:
Keywords: Atrial heart septal defects; Congenital heart disease; Pulmonary veins
Year: 2022 PMID: 35292601 PMCID: PMC9178303 DOI: 10.5090/jcs.21.142
Source DB: PubMed Journal: J Chest Surg ISSN: 2765-1606
Preoperative characteristics (N=22)
| Characteristic | Value |
|---|---|
| Age (mo) | 27.5 (5.0–56.8) |
| Body weight (kg) | 13.2 (6.5–16.0) |
| Male | 9 (40.9) |
| Anatomical characteristics | |
| SVC diameter (mm) | 12.31 (9.29–12.89) |
| Distance of the anomalous PV drainage site from the RA-SVC junction (mm) | 17.5 (11.2–22.4) |
| Distance of ASD from the RA-SVC junction | 14.4 (3.6–21.0) |
| Anomalous PV | |
| RUPV only | 11 (50.0) |
| More than RUPV | 11 (50.0) |
| RMPV to SVC | 5 (22.7) |
| RMPV to RA | 3 (13.6) |
| All RPV to SVC | 1 (4.5) |
| LUPV to innominate vein | 1 (4.5) |
| TAPVR to RA-SVC junction | 1 (4.5) |
| Atrial septal defect | |
| Sinus venosus | 14 (63.7) |
| Isolated secundum | 5 (22.7) |
| Patent foramen ovale | 2 (9.1) |
| Intact atrial septum | 1 (4.5) |
| Associated anomaly | |
| PDA | 3 (13.6) |
| VSD | 2 (9.1) |
| Complete AVSD | 1 (4.5) |
| Coarctation of the aorta | 1 (4.5) |
| TAPVR | 1 (4.5) |
| Pulmonary atresia with VSD | 1 (4.5) |
| Ebstein anomaly | 1 (4.5) |
Values are presented as median (interquartile range) or number (%).
SVC, superior vena cava; PV, pulmonary vein; RA, right atrium; ASD, atrial septal defect; RUPV, right upper pulmonary vein; RMPV, right middle pulmonary vein; RPV, right pulmonary vein; LUPV, left upper pulmonary vein; TAPVR, total anomalous pulmonary venous return; PDA, patent ductus arteriosus; VSD, ventricular septal defect; AVSD, atrioventricular septal defect.
Fig. 1(A) Diagram of preoperative computed tomography measurements. (B) Distal level of the uppermost partial anomalous pulmonary venous return (PAPVR). (C) Level of the superior vena cava (SVC)-right atrium (RA) junction. (D) Level of the lower margin of the atrial septal defect (ASD). Each structure is marked with yellow arrow. The distances from (B) to (C) and from (C) to (D) were measured indirectly in an axial view by multiplying the thickness of the axial image by the number of images. LA, left atrium.
Procedural characteristics (N=22)
| Structure | Procedure | No. (%) |
|---|---|---|
| Atrial septal defect | Left untouched | 13 (59.1) |
| Extension | 8 (36.4) | |
| Creation | 1 (4.5) | |
| Pulmonary venous pathway | Autologous pericardium | 13 (59.1) |
| Polytetrafluoroethylene patch | 8 (36.4) | |
| Bovine pericardium | 1 (4.5) | |
| Systemic venous pathway | Direct implantation | 16 (72.7) |
| Patch augmentation of anterior wall | 3 (13.6) | |
| Autologous pericardial roll | 2 (9.1) | |
| Right atrial wall pedicled flap | 1 (4.5) |
Details of reinterventions
| No. | Age | Body weight (kg) | Concomitant anomaly | ASD type | Patch for baffling | SVC anastomosis | Complication | Reintervention | Interval (Warden–reintervention) (mo) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 10 years | 23.3 | None | Secundum | Bovine pericardium | Autologous pericardial roll | SVC stenosis | SVC stent insertion | 6 |
| 2 | 3 months | 5.8 | Ebstein anomaly | Secundum | GA-fixed autopericardium | Direct anastomosis | SVC stenosis | SVC ballooning | 17 |
| 3 | 28 months | 14.1 | None | Sinus venosus, PFO | PTFE | Direct anastomosis | SVC stenosis | SVC ballooning | 21 |
| 4 | 16 days | 2.9 | CoA, PDA | PFO | PTFE | Direct anastomosis | PV stenosis | Atrial septectomy | 12 |
| 5 | 11 months | 8.7 | PA with VSD, PDA | Intact atrial septum | PTFE | Autologous pericardial roll | PV stenosis, SVC stenosis | Atrial septectomy | 34 |
ASD, atrial septal defect; SVC, superior vena cava; GA, glutaraldehyde; PFO, patent foramen ovale; PTFE, polytetrafluoroethylene; CoA, coarctation of the aorta; PDA, patent ductus arteriosus; PV, pulmonary vein; PA, pulmonary atresia; VSD, ventricular septal defect.
Fig. 2Kaplan-Meier curve of freedom from reintervention after the Warden procedure.
Univariate analysis of potential risk factors for reintervention during follow-up
| Variable | Odds ratio (95% confidence interval) | p-value |
|---|---|---|
| Age <1 yr | 4.875 (0.590–40.258) | 0.274 |
| Body weight | - | 0.493 |
| Male sex | 1.050 (0.137–8.021) | 1.000 |
| Preoperative SVC size | - | 0.497 |
| Preoperative distance (PAPVR to RA-SVC junction) | - | 0.955 |
| Preoperative distance (RA-SVC junction to ASD) | - | 0.734 |
| Abnormal pulmonary vein other than RUPV | 1.688 (0.222–12.809) | 1.000 |
| Concomitant ASD procedure (extension, atrial septectomy) | 9.6 (0.848–108.717) | 0.116 |
| Other concomitant procedures | 2.75 (0.355–21.3) | 0.609 |
| Sinus venosus type ASD | 0.77 (0.007–0.901) | 0.039 |
| Use of autologous pericardial roll | 1.667 (0.815–3.409) | 0.043 |
SVC, superior vena cava; PAPVR, partial anomalous pulmonary venous return; RA, right atrium; ASD, atrial septal defect; RUPV, right upper pulmonary vein.